Sailing between scylla and charybdis—anticoagulation dilemma in a patient with calciphylaxis and mechanical cardiac valve replacement: a case report and literature review

References

• Rick J, Strowd L, Pasieka HB, et al. Calciphylaxis: part I. Diagnosis and pathology. J Am Acad Dermatol. 2022;86(5):1–7. doi:10.1016/j.jaad.2021.10.064.
   PubMed Web of Science ®Google Scholar
• Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018;378(18):1704–1714. doi:10.1056/NEJMra1505292.
   PubMed Web of Science ®Google Scholar
• Gallo Marin B, Aghagoli G, Hu SL, et al. Calciphylaxis and kidney disease: a review. Am J Kidney Dis. 2023;81(2):232–239. doi:10.1053/j.ajkd.2022.06.011.
   PubMed Web of Science ®Google Scholar
• Dobry AS, Nguyen ED, Shah R, et al. The role of skin biopsy in diagnosis and management of calciphylaxis: a retrospective analysis. J Am Acad Dermatol. 2021;85(3):765–767. doi:10.1016/j.jaad.2020.05.101.
   PubMed Web of Science ®Google Scholar
• Oliveira TM, Frazão JM. Calciphylaxis: from the disease to the diseased. J Nephrol. 2015;28(5):531–540. doi:10.1007/s40620-015-0192-2.
   PubMed Web of Science ®Google Scholar
• Bian A, Ye X, Wang J, et al. Therapeutic effects and mechanism of human amnion-derived mesenchymal stem cells on hypercoagulability in a uremic calciphylaxis patient. Ren Fail. 2023;45(1):2218483. doi:10.1080/0886022X.2023.2218483.
   PubMed Web of Science ®Google Scholar
• Roy S, Reddy SN, Garcha AS, et al. Successful treatment of calciphylaxis in a young female with End-Stage renal disease on peritoneal dialysis with parathyroidectomy, intensification of dialysis, and sodium Thiosulphate-A case report and literature review. J Investig Med High Impact Case Rep. 2021;9:23247096211060580. doi:10.1177/23247096211060580.
   Web of Science ®Google Scholar
• McCarthy JT, El-Azhary RA, Patzelt MT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc. 2016;91(10):1384–1394. doi:10.1016/j.mayocp.2016.06.025.
   PubMed Web of Science ®Google Scholar
• Yang X, Liu Y, Xie X, et al. Use of the optimized sodium thiosulfate regimen for the treatment of calciphylaxis in chinese patients. Ren Fail. 2022;44(1):914–922. doi:10.1080/0886022X.2022.2081179.
   PubMed Web of Science ®Google Scholar
• Schlieper G, Brandenburg V, Ketteler M, et al. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol. 2009;5(9):539–543. doi:10.1038/nrneph.2009.99.
   PubMed Web of Science ®Google Scholar
• Krüger T, Brandenburg V, Schlieper G, et al. Sailing between scylla and charybdis: oral long-term anticoagulation in dialysis patients. Nephrol Dial Transplant. 2013;28(3):534–541. doi:10.1093/ndt/gfs485.
   PubMed Web of Science ®Google Scholar
• Thomson BKA, Pilkey NG, Monteith B, et al. A scoping review of alternative anticoagulation strategies for hemodialysis patients with a mechanical heart valve. Am J Nephrol. 2021;52(10-11):861–870. doi:10.1159/000519921.
   PubMed Web of Science ®Google Scholar
• Cadavid JC, DiVietro ML, Torres EA, et al. Warfarin-induced pulmonary metastatic calcification and calciphylaxis in a patient with end-stage renal disease. Chest. 2011;139(6):1503–1506. doi:10.1378/chest.10-1322.
   PubMed Web of Science ®Google Scholar
• Disbrow MB, Qaqish I, Kransdorf M, et al. Calcific uraemic arteriolopathy. BMJ Case Rep. 2015;2015:bcr2014207935. doi:10.1136/bcr-2014-207935.
   PubMedGoogle Scholar
• Berry A, Degheim G, Saba S. Arteriolar vs. valvular thrombosis: pick your evil!. Thromb J. 2018;16:23. doi:10.1186/s12959-018-0175-3.
   PubMed Web of Science ®Google Scholar
• Sohal R, George T. Sodium-Thiosulfate induced Life-Threatening metabolic acidosis limiting treatment of calciphylaxis. Am J Case Rep. 2020;21:e919926. doi:10.12659/AJCR.919926.
   PubMed Web of Science ®Google Scholar
• Diasty ME, Cuenca J. New-onset acute rapidly deteriorating case of calciphylaxis after open heart surgery: a case report. Eur Heart J Case Rep. 2021;5(3):ytab060. doi:10.1093/ehjcr/ytab060.
   PubMedGoogle Scholar
• Hirooka K, Anju K, Moriyama Y, et al. Calciphylaxis after aortic valve replacement in a patient with End-Stage renal disease. Ann Vasc Dis. 2021;14(4):376–379. doi:10.3400/avd.cr.21-00040.
   PubMed Web of Science ®Google Scholar
• Smith MC, Gleaves E, Singh A, et al. Anticoagulation in a patient with mechanical prosthetic valves and calcific uremic arteriolopathy on warfarin. Cureus. 2021;13(3):e14196. doi:10.7759/cureus.14196.
   PubMed Web of Science ®Google Scholar
• Nyembo PF, Eidman KE, Simegn M, et al. Rapidly progressive and catastrophic calciphylaxis after mechanical valve replacement: an anticoagulation dilemma. JACC Case Rep. 2022;4(19):1319–1323. doi:10.1016/j.jaccas.2022.07.034.
   PubMedGoogle Scholar
• Steiner D, Schmaldienst S, Lorenz M, et al. Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort study. Thromb J. 2022;20(1):71. doi:10.1186/s12959-022-00434-7.
   PubMed Web of Science ®Google Scholar
• Carter A, Ortega-Loayza AG, Barrett J, et al. Calciphylaxis with evidence of hypercoagulability successfully treated with unfractionated heparin: a multidisciplinary approach. Clin Exp Dermatol. 2016;41(3):275–278. doi:10.1111/ced.12729.
   PubMed Web of Science ®Google Scholar
• Laugesen EK, Staerk L, Carlson N, et al. Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study. Thromb J. 2019;17:21. doi:10.1186/s12959-019-0211-y.
   PubMed Web of Science ®Google Scholar
• Halperin LF, Lee MK, Liew J, et al. Anticoagulation for patients with atrial fibrillation and End-Stage renal disease on dialysis: a national survey. Can J Cardiol. 2021;37(6):924–928. doi:10.1016/j.cjca.2020.12.005.
   PubMed Web of Science ®Google Scholar
• King BJ, El-Azhary RA, McEvoy MT, et al. Direct oral anticoagulant medications in calciphylaxis. Int J Dermatol. 2017;56(10):1065–1070. doi:10.1111/ijd.13685.
   PubMed Web of Science ®Google Scholar
• Russ P, Russwurm M, Kortus-Goetze B, et al. Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis. BMC Nephrol. 2019;20(1):114. doi:10.1186/s12882-019-1301-6.
   PubMedGoogle Scholar
• Chan N, Sobieraj-Teague M, Eikelboom JW. Direct oral anticoagulants: evidence and unresolved issues. Lancet. 2020;396(10264):1767–1776. doi:10.1016/S0140-6736(20)32439-9.
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369(13):1206–1214. doi:10.1056/NEJMoa1300615.
   PubMed Web of Science ®Google Scholar
• Duraes AR, de Souza Lima Bitar Y, Schonhofen IS, et al. Rivaroxaban versus warfarin in patients with mechanical heart valves: open-Label, proof-of-Concept trial-The RIWA study. Am J Cardiovasc Drugs. 2021;21(3):363–371. doi:10.1007/s40256-020-00449-3.
   PubMed Web of Science ®Google Scholar
• Ryu R, Tran R. DOACs in mechanical and bioprosthetic heart valves: a narrative review of emerging data and future directions. Clin Appl Thromb Hemost. 2022;28:10760296221103578. doi:10.1177/10760296221103578.
   Web of Science ®Google Scholar
• Kato ET, Giugliano RP, Ruff CT, et al. Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. J Am Heart Assoc. 2016;5(5):e003432. doi:10.1161/JAHA.116.003432.
   PubMed Web of Science ®Google Scholar
• Jain N, Reilly RF. Clinical pharmacology of oral anticoagulants in patients with kidney disease. Clin J Am Soc Nephrol. 2019;14(2):278–287. doi:10.2215/CJN.02170218.
   PubMed Web of Science ®Google Scholar
• Ryu R. DOACs in valvular heart disease: latest key updates on PROACT Xa (apixaban) and INVICTUS (rivaroxaban). Clin Appl Thromb Hemost. 2022;28:10760296221144044. doi:10.1177/10760296221144044.
   Web of Science ®Google Scholar
• Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2021;143(5):e35–e71. doi:10.1161/CIR.0000000000000932.
   PubMed Web of Science ®Google Scholar
• Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632. doi:10.1093/eurheartj/ehab395.
   PubMed Web of Science ®Google Scholar
• Ikeno Y, Mukohara N, Fukumura Y, et al. Outcomes of valve replacement with mechanical prosthesis versus bioprosthesis in dialysis patients: a 16-year multicenter experience. J Thorac Cardiovasc Surg. 2019;158(1):48–56.e4. doi:10.1016/j.jtcvs.2018.11.089.
   PubMed Web of Science ®Google Scholar
• Li GY, Chen YY, Chung FP, et al. Long-Term outcomes of bioprosthetic or mechanical valve replacement in End-Stage renal disease: a nationwide Population-Based retrospective study. Front Cardiovasc Med. 2021;8:745370. doi:10.3389/fcvm.2021.745370.
   PubMed Web of Science ®Google Scholar
• Ngendahimana DK, Deo SV, Sundaram V, et al. Outcomes of surgical mitral and aortic valve replacements among kidney transplant candidates: implications for valve selection. J Am Heart Assoc. 2021;10(5):e018971. doi:10.1161/JAHA.120.018971.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang X, Xie X, et al. Risk factors for calciphylaxis in chinese hemodialysis patients: a matched case-control study. Ren Fail. 2021;43(1):406–416. doi:10.1080/0886022X.2021.1884094.
   PubMed Web of Science ®Google Scholar
• Farah M, Crawford RI, Levin A, et al. Calciphylaxis in the current era: emerging ‘ironic’ features? Nephrol Dial Transplant. 2011;26(1):191–195. doi:10.1093/ndt/gfq407.
   PubMed Web of Science ®Google Scholar
• Monegal A, Peris P, Alsina M, et al. Development of multiorganic calciphylaxis during teriparatide, vitamin D, and calcium treatment. Osteoporos Int. 2016;27(8):2631–2634. doi:10.1007/s00198-016-3571-1.
   PubMed Web of Science ®Google Scholar